<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="159815">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01980394</url>
  </required_header>
  <id_info>
    <org_study_id>Liestal-2012-OES</org_study_id>
    <nct_id>NCT01980394</nct_id>
  </id_info>
  <brief_title>Esophageal Stump Washout</brief_title>
  <official_title>Esophageal Stump Washout Reduces Free Intraluminal Tumor Cells During Resection of Carcinomas of the Esophagus and Cardia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kantonsspital Liestal</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Bern</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Kantonsspital Liestal</source>
  <oversight_info>
    <authority>Switzerland: Federal Office of Public Health</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Intraluminally shed viable tumor cells might contribute to local recurrence in cancer of the
      esophagus and the cardia. The aim of the the study was to establish a method of mechanical
      lavage of the remaining part of the esophagus and, hence, to reduce the intraluminal cancer
      cells before doing the esophageal anastomosis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      See study protocol!
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2004</start_date>
  <completion_date type="Anticipated">December 2013</completion_date>
  <primary_completion_date type="Anticipated">December 2013</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <study_design>Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Presence of intraluminal tumor cells in the remaining oesophageal stump</measure>
    <time_frame>during the operation</time_frame>
    <safety_issue>Yes</safety_issue>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Esophageal Cancer</condition>
  <condition>Cancer of the Gastro-esophageal Junction</condition>
  <arm_group>
    <arm_group_label>prospective cohort study</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Esophageal Stump Washout</intervention_name>
    <description>a washout of the closed esophageal stump with Ringer-solution (10 times 30ml) is performed by means of a transorally inserted 24F-Foley catheter. The first, fifth and tenth portion of the lavage fluid are collected and sent to cytological examination</description>
    <arm_group_label>prospective cohort study</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  histologically confirmed cancer of gastro-esophageal junction with indication for
             surgery

        Exclusion Criteria:

          -  missing informed consent
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>95 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christoph A. Maurer, Professor, Chairman of Surgery</last_name>
    <role>Study Chair</role>
    <affiliation>Hospital of Liestal, Liestal, Switzerland</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Kantonsspital Baselland, Liestal</name>
      <address>
        <city>Liestal</city>
        <state>Basel-Land</state>
        <zip>4410</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christoph A Maurer, MD</last_name>
      <phone>+41 61 925 21 50</phone>
      <email>christoph.maurer@ksli.ch</email>
    </contact>
    <investigator>
      <last_name>Diana R Mattiello, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>November 2013</verification_date>
  <lastchanged_date>November 4, 2013</lastchanged_date>
  <firstreceived_date>August 30, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>esophagus</keyword>
  <keyword>gastro-esophegeal junction</keyword>
  <keyword>cancer</keyword>
  <keyword>tumor seeding</keyword>
  <keyword>free viable tumor cells</keyword>
  <keyword>surgery</keyword>
  <keyword>intraluminal tumor cells</keyword>
  <keyword>stump washout</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Esophageal Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
